Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Surgery Trials

Texas

Colorectal cancer surgery and procedure trials in Texas

18 colorectal cancer surgery and procedure studies are recruiting participants at sites in 7 cities across Texas as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 929-5740
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Texas city with a recruiting study

Houston (12), Dallas (3), San Antonio (3), Amarillo (1), Fort Worth (1), Forth Worth (1), Richardson (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Texas

Basic details from each study's public record (the 12 most recently updated of 18). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    San Antonio
    Registry record
    NCT06995898 · updated
  2. Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT03594630 · updated
  3. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Dallas · Fort Worth · Richardson
    Registry record
    NCT05863195 · updated
  4. Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT04739072 · updated
  5. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Houston
    Registry record
    NCT06102902 · updated
  6. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    San Antonio
    Registry record
    NCT05080673 · updated
  7. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Amarillo · Houston · San Antonio
    Registry record
    NCT05334069 · updated
  8. Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT02863172 · updated
  9. Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Houston
    Registry record
    NCT07551596 · updated
  10. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Recruiting in
    Houston
    Registry record
    NCT04851119 · updated
  11. An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT04796818 · updated
  12. Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

    • Phase 2/3
    • Ages 18 to 80
    • All sexes
    Sponsor
    Sir Mortimer B. Davis - Jewish General Hospital
    Recruiting in
    Dallas
    Registry record
    NCT03051464 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Texas on ClinicalTrials.gov.

Ask about studies in Texas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Colorectal Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 929-5740

or send a short form

How should we reach you?

Call